RECRUITINGOBSERVATIONAL
Identification of Risk Factors, Exposomics and Genetic Susceptibility of Melanoma in Children, Adolescents and Young Adults
Identification of Risk Factors, Exposomics and Genetic Susceptibility of Melanoma in Children, Adolescents and Young Adults - Novel Health Care Strategies for Melanoma in Children, Adolescents and Young Adults (MELCAYA)
About This Trial
The primary objective of this study is the identification of environmental and genetic factors involved in the risk and progression of melanoma in children, adolescents and young adults (CAYA). The secondary objectives are to generate a model integrating the genetic and environmental factors to estimate the risk of developing melanoma and improve the primary prevention of melanoma through evidence-based interpretation of environmental risk.
Who May Be Eligible (Plain English)
Who May Qualify:
- confirmed melanoma
- age until 30 years old
Who Should NOT Join This Trial:
- no available biological material
- no signed willing to sign a consent form
Always talk to your doctor about whether this trial is right for you.
Original Eligibility Criteria
View original clinical language
Inclusion Criteria:
* confirmed melanoma
* age until 30 years old
Exclusion Criteria:
* no available biological material
* no signed informed consent
Locations (6)
Leibniz Research Institute for Environmental Medicine
Düsseldorf, Germany
University of Florence
Florence, Italy
Istituto Nazionale del Tumori
Milan, Italy
Medical University of Gdánsk
Gdansk, Poland
Hospital Clínic de Barcelona
Barcelona, Spain
Karolinska Institute
Solna, Sweden